Explore more publications!
Nepal Healthcare Times
Got News to Share?

Nepal Healthcare Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Nepal Healthcare Times.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on November 21, 2025

OKYO Pharma Announces Chairman and Founder Acquires Shares
November 21, 2025

OKYO Pharma Announces Chairman and Founder Acquires Shares

Indeterminate GlobeNewswire
New Data at the Asia Pacific Heart Rhythm Society (APHRS) 2025 Highlight the Performance of iRhythm’s Zio Long-Term Continuous Monitoring in an Asian Population
November 21, 2025

New Data at the Asia Pacific Heart Rhythm Society (APHRS) 2025 Highlight the Performance of iRhythm’s Zio Long-Term Continuous Monitoring in an Asian Population

Indeterminate GlobeNewswire
第18回アジア太平洋不整脈学会学術大会（APHRS2025）で発表された新たなデータにより　アジア人集団におけるiRhythm社のZio長期連続モニタリングの性能が明らかに
November 21, 2025

第18回アジア太平洋不整脈学会学術大会（APHRS2025）で発表された新たなデータにより　アジア人集団におけるiRhythm社のZio長期連続モニタリングの性能が明らかに

Indeterminate GlobeNewswire
60 Degrees Pharmaceuticals Announces Clinical Site Now Open for Patient Enrollment for the B-FREE Chronic Babesiosis Study at Mount Sinai Icahn School of Medicine
November 21, 2025

60 Degrees Pharmaceuticals Announces Clinical Site Now Open for Patient Enrollment for the B-FREE Chronic Babesiosis Study at Mount Sinai Icahn School of Medicine

Indeterminate GlobeNewswire
XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V.
November 21, 2025

XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V.

Indeterminate GlobeNewswire
Actimed Therapeutics Announces Important Licensing Agreement with Mankind Pharma
November 21, 2025

Actimed Therapeutics Announces Important Licensing Agreement with Mankind Pharma

Indeterminate GlobeNewswire
Anaptys Announces $100 Million Stock Repurchase Plan
November 21, 2025

Anaptys Announces $100 Million Stock Repurchase Plan

Indeterminate GlobeNewswire
Anaptys Initiates Litigation Against Tesaro, a GSK Subsidiary
November 21, 2025

Anaptys Initiates Litigation Against Tesaro, a GSK Subsidiary

Indeterminate GlobeNewswire
Inhibikase Therapeutics Announces Pricing of $100 Million Public Offering of Common Stock and Pre-Funded Warrants
November 21, 2025

Inhibikase Therapeutics Announces Pricing of $100 Million Public Offering of Common Stock and Pre-Funded Warrants

Indeterminate GlobeNewswire
Seren Advanced Dentistry Oxnard Announces Implementation of Biomimetic Conservative Dentistry Led by Dr. Ette Ntekim
November 21, 2025

Seren Advanced Dentistry Oxnard Announces Implementation of Biomimetic Conservative Dentistry Led by Dr. Ette Ntekim

Indeterminate GlobeNewswire
NovaBridge’s Visara Subsidiary Appoints Distinguished Ophthalmology Leaders as Chief Medical Officer and Scientific Advisory Board Chair to Drive VIS-101 Forward
November 21, 2025

NovaBridge’s Visara Subsidiary Appoints Distinguished Ophthalmology Leaders as Chief Medical Officer and Scientific Advisory Board Chair to Drive VIS-101 Forward

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions